ArticleJournal of general internal medicine2008
Contents of general practitioner-patient consultations in the treatment of depression.
Article in Journal of general internal medicine, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Guidance by physicians and pharmacists during antidepressant therapy: patients' needs and suggestions for improvement.BMC psychiatry · 2017Article
- Facilitating understanding of mental health problems in GP consultations: a qualitative study using taped-assisted recall.The British journal of general practice : the journal of the Royal College of General Practitioners · 2010Article
- Educating and informing patients receiving psychopharmacological medications: are family physicians in Pakistan up to the task?PloS one · 2009Article
- Treatment Changes in General Practice Patients With Chronic Mental Disorders Following a Psychiatric-Psychosomatic Consultation.Health services research and managerial epidemiologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCounseling of patients is an indispensable part of any drug treatment and even more so in the treatment of depression.
objectiveTo describe the content of counseling additional to prescribing an antidepressant drug.
settingSixty-three general practices from all over Germany. PATIENTS: Three hundred two patients with the diagnosis of either a depressive episode or a recurrent depressive disorder. MEASUREMENTS: Assessment of the content of the physician-patient encounter by content analysis following the pivotal topic method.
designQualitative study embedded in a drug utilization study on mirtazapine.
resultsIn the initial sessions general practitioners focused on building a good therapeutic alliance, assessing the symptoms of illness, explaining the course of treatment, assuring medication compliance, and discussing problems of life. In the middle phase of treatment, physicians also dealt with building a therapeutic alliance, medication compliance, and the progress and course of illness. In the last phase relapse prevention was an important topic. Psychological topics were more important than medication topics. Almost no importance was given to management of side effects, change of cognitions, or suicidal tendencies. LIMITATIONS: No information is available on how content was actually discussed. Only encounters were observed where an antidepressant was prescribed.
conclusionsCounseling plays an important part in day-to-day encounters of general practitioners. Pharmacotherapy is embedded in comprehensive psychological care. Training programs for general practitioners should be specific in respect to different tasks and parts of the physician-patient encounter (e.g., building a therapeutic alliance, support for life problems or change of cognitions).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.